Last reviewed · How we verify
NCT05556668
Percutaneous Biodegradable Biliary Stents for the Treatment of Benign Biliary Strictures.
trial testing Percutaneous placement of biodegradable biliary stents in Biliary Stricture in 50 participants. Completed in 20 December 2022.
5 November 2022
Quick facts
| Lead sponsor | Corporacion Parc Tauli |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 20 August 2022 |
| Primary completion | 5 November 2022 |
| Estimated completion | 20 December 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Percutaneous placement of biodegradable biliary stents
Conditions studied
- Biliary Stricture — all drugs for Biliary Stricture →
- Biliary Tract Diseases — all drugs for Biliary Tract Diseases →
- Bile Duct Stricture — all drugs for Bile Duct Stricture →
- Bile Duct Injury — all drugs for Bile Duct Injury →
Sponsor
Corporacion Parc Tauli — full company profile →
Who can join
18 and older, any sex, with Biliary Stricture or Biliary Tract Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess safety and effectiveness in the long term of percutaneous insertion of Biodegradable (BD) Biliary Stents for the treatment of benign biliary strictures, in a single center experience.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05556668
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Percutaneous placement of biodegradable biliary stents
Trials testing the same drug.
- NCT04115696 — Biodegradable Stent Implantation in Biliary Benign Strictures. · completed
Other recruiting trials for Biliary Stricture
Currently open trials in the same condition.
- NCT06277531 — Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) · recruiting
- NCT06964425 — Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study · NA · recruiting
- NCT03977779 — Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancrea · NA · recruiting
- NCT05210322 — Percutaneous Cholangiopancreatoscopy Registry · active not recruiting
- NCT05761483 — Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation. · recruiting
Other Corporacion Parc Tauli trials
Trials by the same sponsor.
- NCT07331805 — Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study · NA · not yet recruiting
- NCT06873360 — Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients · completed
- NCT06900335 — Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact · completed
- NCT06511700 — Implementation of the Intravitreal Injection Administered by Nurses · enrolling by invitation
- NCT07298720 — Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05556668 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Corporacion Parc Tauli
- Last refreshed: 1 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05556668.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing